Literature DB >> 19088303

Kinetics of cellular retention during Caco-2 permeation experiments: role of lysosomal sequestration and impact on permeability estimates.

Aki T Heikkinen1, Jukka Mönkkönen, Timo Korjamo.   

Abstract

The permeability estimation from cell monolayer permeation data is usually based on 100% recovery assumption. However, poor recovery is often seen in such experiments in practice but often neglected in data interpretation. In the present study, the cellular retention kinetics during Caco-2 permeation experiments of three passively transported compounds, weakly basic propranolol [(+/-)-1-isopropylamino-3-(1-naphthyloxy)-2-propanol], weakly acidic ibuprofen [alpha-methyl-4-(isobutyl)phenylacetic acid], and neutral testosterone (17beta-hydroxy-4-androsten-3-one), were determined. Furthermore, the effects of cellular retention kinetics on apparent permeability were evaluated, and the role of lysosomal sequestration in cellular retention of propranolol was explored. The cellular retention profiles were observed to be direction and concentration dependent, which may cause erroneous directionality and concentration dependence in permeability estimates. Furthermore, the lysosomal sequestration was demonstrated to contribute to the extent and kinetics of the cellular retention of propranolol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088303     DOI: 10.1124/jpet.108.145797

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

2.  Consideration of the Unbound Drug Concentration in Enzyme Kinetics.

Authors:  Nigel J Waters; R Scott Obach; Li Di
Journal:  Methods Mol Biol       Date:  2021

3.  Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.

Authors:  Thomas A Munro; Loren M Berry; Ashlee Van't Veer; Cécile Béguin; F Ivy Carroll; Zhiyang Zhao; William A Carlezon; Bruce M Cohen
Journal:  BMC Pharmacol       Date:  2012-05-29

4.  Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: A mechanistic model.

Authors:  Kai Bittermann; Kai-Uwe Goss
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

5.  Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract.

Authors:  Noel P Pitcher; Jitendra R Harjani; Yichao Zhao; Jianwen Jin; Daniel R Knight; Lucy Li; Papanin Putsathit; Thomas V Riley; Glen P Carter; Jonathan B Baell
Journal:  ACS Omega       Date:  2022-02-18

6.  In Vitro-In Silico Modeling of Caffeine and Diclofenac Permeation in Static and Fluidic Systems with a 16HBE Lung Cell Barrier.

Authors:  Lukas Kovar; Lena Wien; Dominik Selzer; Yvonne Kohl; Robert Bals; Thorsten Lehr
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-18

7.  Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds.

Authors:  Kasiram Katneni; Thao Pham; Jessica Saunders; Gong Chen; Rahul Patil; Karen L White; Nada Abla; Francis C K Chiu; David M Shackleford; Susan A Charman
Journal:  Pharm Res       Date:  2018-09-17       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.